top of page

Search Results

46 results found for "InterAx Biotech"

  • Ep 21 with Dr. Maria Waldhoer

    and at the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief Scientific Officer. Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr.

  • Ep 144 with Dr Aurélien Rizk

    He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr. They wrapped up the conversation by discussing job opportunities at Interax Biotech and their anticipation Aurelien Rizk, a co-founder and CEO of Interax Biotech, shared about the company's development of a discovery The discussion concluded with a brief overview of job opportunities at Interax Biotech, with Aurelien

  • Biotech Growth | Dr. GPCR Ecosystem

    Home CRO Advisory Biotech Growth Blog Free Intro Call About Get in Touch Menu Home Who I work with Services talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

  • CRO Advisory | Dr. GPCR Ecosystem

    Home CRO Advisory Biotech Growth Blog Free Intro Call About Get in Touch Menu Home Who I work with Services talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

  • Yamina's Corner | Dr. GPCR Ecosystem

    News Get in Touch Home: Welcome Accelerating GPCR Discovery with Strategic Execution I work across biotech — but we can’t make decisions. ❌ We thought the CRO had it covered. ❌ The right tools — but limited biotech Advisory Focus Areas Expert support for Biotech innovators, VC investors and CRO partners Biotech Growth Fast-Track Discovery CRO & Vendor Advisory Discovery runs smoother when CRO & Vendor services match biotech With over 20 years of experience in GPCR pharmacology across biotech, academia, and the nonprofit space

  • Ep 163 with Dr. Dmitry Veprintsev

    . ✅ Building Z7 Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling services to pharma and biotech companies. ✅ Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions, and novel profiling approaches. ✅ Networking & Career In 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision Dmitry Veprintsev on the web LinkedIn Veprintsev Lab Z7 Biotech University of Nottingham Thanks for listening

  • Ep 84 with Rosie Dawaliby

    I developed G.CLIPS biotech's innovative technology as a synthesis of the different knowledge, experiences Before founding G.CLIPS biotech in June 2020. GPCR Ecosystem G.CLIPS Biotech on the web Website LinkedIn Thanks for listening to this podcast episode

  • Contact Yamina | Dr. GPCR Ecosystem

    Home Services CRO Advisory Biotech Growth Blog Free Intro Call About Get in Touch Say Hello This is your talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

  • Yamina's Services | Dr. GPCR Ecosystem

    Home CRO Advisory Biotech Growth Blog Free Intro Call About Get in Touch Our Services This is your Services talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

  • Media Partner | Dr. GPCR Ecosystem

    As a media partner, you’ll gain trusted access to an engaged audience of academic researchers, biotech partner, you’ll be featured across our nonprofit platform trusted by thousands of GPCR scientists and biotech

  • Ep 136 with Murat Tunaboylu & Ben Holland

    After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer He has co-founded consultancy and biotech companies Svarlight and Antiverse. start-up and in 5 years was responsible for project R&D and managing a focused development team, pursued international

  • Ep 31 with Dr. Kevin Pfleger

    Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the academic and biotech Personalised Therapeutics Technologies, Chief Scientific Advisor to Dimerix, and co-founder of RAGE Biotech Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International

  • Ep 169 with Dr. Sokhom Pin

    welcome Sokhom Pin , Head of Biology at Superluminal Medicines , whose career spans decades in the biotech candid conversation that traces Sokhom’s inspiring journey—from lab technician at Johns Hopkins to biotech The episode ends with practical advice on networking, leadership development , and navigating biotech

  • Media Partner Packages | Dr. GPCR Ecosystem

    As a media partner, you'll gain trusted access to an engaged audience of academic researchers, biotech partner, you'll be featured across our nonprofit platform trusted by thousands of GPCR scientists and biotech ✓ 📣 Social Media Promotion Engaging posts about your organization Targeted to GPCR researchers and biotech

  • About Yamina | Dr. GPCR Ecosystem

    Home CRO Advisory Biotech Growth Blog Free Intro Call About Get in Touch Alex Young Project Manager Phone talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

  • Flash News / DrGPCR

    Dmitry Veprintsev #DrGPCR #GPCRPodcast #Biotech #Pharmacology #GPCRScience Apr 8, 2025 In Ep.163 of the -dmitry- #GPCRs #SciencePodcast #DrugDiscovery #Biotech #DrGPCR Apr 1, 2025 New Episode Alert! 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast your schedule 🚀 Elevate your expertise today: Start learning now #GPCR #Pharmacology #DrugDiscovery #Biotech GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery Dr.

  • Ep 137 with Dr. Josh Pottel

    More broadly, I hope to be a critical contributor to a growing Canadian biotech sector in both scientific

  • Ep 117 with Dr. Pierre Eftekhari

    Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs for our pharma and biotech

  • Ep 25 with Dr. Annette Gilchrist

    Annette worked in industry, academia and her entrepreneurial side led her to three companies, Cue Biotech

  • Ep 37 with Dr. Samuel Hoare

    As an industry pharmacologist, he consults with numerous pharma and biotechs in understanding and applying

  • Ep 95 with Chris Langmead

    neuroscience R&D program with Servier (France) and is the co-founder and CEO of Phrenix Therapeutics, a biotech Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology

  • Ep 151 with Dr GPCR Board

    pharmacologist with a ~30 years background in academia and industry, working both in big pharma and biotech at Novo Nordisk A/S allowed me to shape a swiss start-up company from a scientifc idea to a thriving Biotech Trejo has presented her studies at 52 national/international meetings and 66 academic seminars across

  • Ep 150 with Dr GPCR Team

    She received her undergraduate degree in Biotechnology from KIIT University in India. his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical and biotech of Pharmaceutical Sciences, Monash University, with a deep interest in understanding drug-receptor interactions

  • Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling

    About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Interaction

  • Dr. GPCR Summit 2021 | Dr. GPCR Ecosystem

    Everyone is welcome to present their work (students, postdocs, PI's, biotech, pharma companies)!

  • "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways

    : RAMP-interacting GPCR Pathways Date & Time Thursday, November 2nd / 4:30 PM !

  • Ep 152 with Dr Arthur Christopoulos

    He has received substantial, long-term support from international and national competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology companies Professor Christopoulos has over 360 publications, including in leading international journals such as He has served on the Editorial Board of 8 international journals and was a Councillor of the International his experiences in the pharmaceutical industry, highlighting the differences between big pharma and biotech

  • Terms and Conditions | Dr. GPCR Ecosystem

    is an online platform that provides to (i) individuals and businesses such as scientists, students, biotech others with access to advertise, to promote, and market their services and products related to the biotech Either party in this agreement may seek any interim or preliminary relief from a court of competent jurisdiction

Powered by


All Rights Reserved © 2020 - 2024

Dr. GPCR CORP is a 501(c)(3) non profit organization

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
bottom of page